Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (111-120 of 216) with videos related to

Pageof 22
Sort By:
Blood|September 27, 2003
Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia ABrian D Brown, Chang Xin Shi, Sandra Powell, et al.
Blood|October 23, 2004
Cell type-specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressorChristine Hough, Carla D Cuthbert, Colleen Notley, et al.
The Lancet. Haematology|November 5, 2025
Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implicationsOmid Seidizadeh, Ferdows Atiq, Nathan T Connell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 29, 2019
Challenges in diagnosis of von Willebrand disease in the presence of combined mutations of different genesTiago Nava, Evemie Dubé, Julie Gauthier, et al.
British Journal of Haematology|November 7, 2008
ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factorCynthia M Pruss, Colleen R P Notley, Carol A Hegadorn, et al.
Journal of Thrombosis and Haemostasis : JTH|June 21, 2021
Stabilin-2 deficiency increases thrombotic burden and alters the composition of venous thrombi in a mouse modelAlison Michels, Laura L Swystun, Courtney N Dwyer, et al.
Blood|September 26, 2008
Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 responseBraden Waters, Mohammad Qadura, Erin Burnett, et al.
Blood|May 5, 2009
Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A miceMohammad Qadura, Braden Waters, Erin Burnett, et al.
Blood|February 12, 2005
Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand diseaseMaha Othman, Colleen Notley, Frances Louise Lavender, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2024
The history of women and hemophilia: a narrative review of evolving beliefs and testing practicesMegan Chaigneau, Mackenzie Bowman, Pamela Wilton, et al.
Pageof 22

Showing results (111-120 of 216) with videos related to

Sort By:
Pageof 22
Blood|September 27, 2003
Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia ABrian D Brown, Chang Xin Shi, Sandra Powell, et al.
Blood|October 23, 2004
Cell type-specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressorChristine Hough, Carla D Cuthbert, Colleen Notley, et al.
The Lancet. Haematology|November 5, 2025
Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implicationsOmid Seidizadeh, Ferdows Atiq, Nathan T Connell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 29, 2019
Challenges in diagnosis of von Willebrand disease in the presence of combined mutations of different genesTiago Nava, Evemie Dubé, Julie Gauthier, et al.
British Journal of Haematology|November 7, 2008
ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factorCynthia M Pruss, Colleen R P Notley, Carol A Hegadorn, et al.
Journal of Thrombosis and Haemostasis : JTH|June 21, 2021
Stabilin-2 deficiency increases thrombotic burden and alters the composition of venous thrombi in a mouse modelAlison Michels, Laura L Swystun, Courtney N Dwyer, et al.
Blood|September 26, 2008
Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 responseBraden Waters, Mohammad Qadura, Erin Burnett, et al.
Blood|May 5, 2009
Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A miceMohammad Qadura, Braden Waters, Erin Burnett, et al.
Blood|February 12, 2005
Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand diseaseMaha Othman, Colleen Notley, Frances Louise Lavender, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2024
The history of women and hemophilia: a narrative review of evolving beliefs and testing practicesMegan Chaigneau, Mackenzie Bowman, Pamela Wilton, et al.
Pageof 22